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Background: Although an association between low-level environmental heavy metal exposure and the incidence
of metabolic syndrome (MS) has been hypothesized, little research on this topic has been conducted on a
population-wide level.
Methods: We analyzed MS status and whole blood lead, mercury, cadmium, manganese, and creatinine-adjusted
urine arsenic concentrations in 1,405 subjects, ≥ 20 years of age, who were registered for the Korea National Health
and Nutrition Examination Survey, 2008.
Results: Various demographic and biochemical parameters were associated with MS and blood heavy metal status.
After adjusting for these variables, lead was the only heavy metal that was significantly associated with MS. Lead
concentrations in subjects with MS were significantly higher than those in subjects without MS (p = 0.015). The
prevalence of MS and a moderate/high risk for cardiovascular disease, as determined by Framingham risk score,
also increased significantly according to the logarithmic transformation of the lead quartile (p < 0.001). The odds
ratios and 95% confidence intervals for MS were 1.56 (0.90–2.71), 1.63 (0.94–2.83), and 2.57 (1.46–4.51) for the
second, third, and fourth quartiles of the log-transformed lead quartile, respectively, as compared with those of the
lowest quartile after multiple adjustments for confounding factors. Serum triglyceride level was the only MS
diagnostic component significantly associated with lead level in a multiple linear regression analysis (p = 0.006).
Conclusions: These findings suggest that a higher prevalence of MS is associated with higher blood lead levels in
the Korean population.
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Tremendous changes in lifestyles and environments have
occurred through rapid industrialization, and these
changes have significantly affected human health. Mor-
bidity and mortality caused by nutritional deficiencies
and contagious diseases have decreased sharply, whereas
obesity, diabetes mellitus (DM), and malignant tumors* Correspondence: jtwoomd@khmc.or.kr
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reproduction in any medium, provided the orhave become highly prevalent [1,2]. Various factors rele-
vant to these chronic diseases have been identified as risk
factors after a great deal of research [3,4]. In particular,
various environmental factors other than conventional risk
factors have been proposed to be independently related to
both the onset and progression of chronic diseases. More-
over, it is believed that various environmental factors have
an additive or synergistic effect on chronic diseases in
combination with conventional risk factors [5,6].
Some studies have suggested that environmental expo-
sure to heavy metals, such as lead and arsenic, is closely
associated with the prevalence of chronic diseases, such asd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[7-9]. However, these studies focused on a limited number
of subjects from a few areas; the association between
environmental exposure to heavy metals and chronic
metabolic diseases has rarely been investigated using a
population-based approach. Consequently, little is known
about how environmental exposure to heavy metals affects
various chronic diseases.
Raw data from the Korea National Health and Nutrition
Examination Survey (KNHANES) IV, which was con-
ducted by the Korea Centers for Disease Control and
Prevention, were released in 2011. The KNHANES IV
data include blood and urine assays for heavy metals. Our
aim in this study was to determine if there was an associ-
ation between environmental exposure to heavy metals
and metabolic syndrome (MS). Our analyses were based
on the KNHANES 2008 data, which were collected from a
representative sample of the noninstitutionalized civilian
population in Korea.Methods
Study subjects
KNHANES is a nationwide, population-based, and cross-
sectionally designed health survey conducted by the Korea
Centers for Disease Control and Prevention. After the first
KNHANES was conducted in 1998, the second, third,
and fourth surveys were conducted in 2001, 2005, and
2007–2009, respectively.
We utilized the KNHANES 2008 data, which included
information on MS diagnoses and heavy metal sampling.
Heavy metal sampling was conducted on 2,000 subjects
by randomly selecting 10 subjects from each survey unit
according to age and sex. Blood samples were collected
for analyses of lead, mercury, cadmium, and manganese
concentrations, and urine samples were collected to as-
sess total arsenic concentrations.
Subjects whose age ranged from ≥ 20 years to < 80 years
were selected from among the group of subjects who were
tested for heavy metals (n = 1,791). Within this group,
people who took medications for hypertension, DM, or
dyslipidemia (n = 307) were excluded to eliminate the
effects of medications on MS. We also excluded patients
with active chronic diseases that might have contributed
to MS (n = 51). In addition, we excluded subjects with
demographic and clinical variables missing from their
health interview and health examination (n = 28) records,
including body mass index (BMI), education, occupation,
physical activity, and other variables for MS diagnosis and
CVD risk estimation. We included patients with cere-
brovascular disease, CVD, active tuberculosis, chronic
obstructive pulmonary disease, chronic kidney disease,
chronic liver disease, and malignancy. Thus, data from
1,405 people were analyzed.Study methods
The subjects were subdivided according to the character-
istics of each variable to determine differences based on
demographic and clinical characteristics. The Modified
National Cholesterol Education Program Adult Treatment
Panel III criteria were used for subjects with a diagnosis of
MS [10]. However, waist circumference measurements
of ≥ 90 cm in males and ≥ 85 cm in females were selected
in the MS diagnosis based on the criteria of the Korean
Society for the Study of Obesity [11]. The 10-year CVD
risk of subjects was also assessed using the Framingham
risk score [12]. Based on these results, subjects were clas-
sified into low-risk (< 5%), moderate-risk (5% to < 10%),
and high-risk groups (≥10%) [10]. Current smokers were
defined as those who had smoked more than five packs of
cigarettes during their lifetime and were smoking at the
time of the survey; all others subjects were defined as
non-smokers. Regular alcohol drinkers were those who
currently drank alcohol more than once per month, and
all others were defined as non-drinkers. The 16 residential
areas of the KNHANES were classified into two groups: 1)
urban areas, including metropolitan cities such as Seoul,
Busan, Daegu, Incheon, Gwangju, Daejeon, and Ulsan, as
well as metropolitan areas such as Gyeonggi province;
and 2) rural areas, comprising Gangwon, Chungbuk,
Chungnam, Jeonnam, Jeonbuk, Gyeongbuk, Gyeongnam,
and Jeju provinces. Educational status was categorized as
follows: 1) graduation from elementary school or lower; 2)
graduation from middle school; 3) graduation from high
school; and 4) graduation from college or higher. Seven
occupation types were recognized: 1) managers, profes-
sionals, technicians, and associated professionals; 2) cler-
ical support workers; 3) service and sales workers; 4)
skilled agricultural, forestry, and fishery workers; 5) craft
and related trades workers, plant and machine operators,
and assemblers; 6) elementary occupations; and 7) house-
wife, student, or unemployed, based on the 6th Korean
Standard Classification of Occupations from the Korean
National Statistical Office, which was created by following
the International Standard Classification of Occupations
of the International Labor Organization [13]. Physical ac-
tivity of the subjects was investigated by evaluating their
participation in recreational physical activity during the
1 week prior to the survey and categorized as follows:
1) none, no or minimal activity; 2) mild, > 30 minutes of
walking more than 5 days per week; 3) moderate, > 30
minutes of physical activity in which the subject was tired
compared to normal or breathing slightly hard more than
5 days per week; and 4) vigorous, > 20 min of vigorous
physical activity in which the subject was exhausted com-
pared to normal or breathing hard more than 3 days per
week.
Samples from all subjects were collected after a period of
fasting for 8 hours or longer. Specimens were immediately
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Institute, Seoul, Korea), where they were analyzed within
24 hours. This central laboratory is certified by the Ministry
of Labor of Korea as one of the designated laboratories for
assaying the levels of special chemicals, including heavy
metals. For external quality assurance and control, this
laboratory is required to fulfill all the requirements of the
Quality Assurance Program operated by the Korea Occupa-
tional Safety and Health Agency, and to have passed the
German External Quality Assessment Scheme.
Biochemical measurements, including total cholesterol,
triglycerides, high-density lipoprotein (HDL) cholesterol,
blood urea nitrogen (BUN), creatinine, aspartate amino-
transferase (AST), alanine aminotransferase (ALT), and
fasting plasma glucose concentrations were assessed using
an automated analyzer (Hitachi Automatic Analyzer 7600;
Tokyo, Japan) with enzymatic assays. HDL cholesterol was
evaluated using standard samples as equivalents between
the KNHANES central laboratory and the U.S. Centers For
Disease Control and Prevention to produce an accurate
lipid profile. The differences between the two laboratories
were adjusted for by Passing–Bablok regression [14]. Low-
density lipoprotein (LDL) cholesterol levels were calculated
using the Friedewald equation [15]. Serum insulin concen-
trations were measured using a gamma counter (1470
Wizard, Perkin Elmer, Turku, Finland) and an immunora-
diometric assay (Biosource, Nivelles, Belgium).
Trace element EDTA tubes (BD, Franklin Lakes, NJ,
USA) were used to store blood samples for the heavy
metal assays. More than 20 mL of clean midstream urine
was collected as the urine sample. Lead, cadmium, man-
ganese, and urine total arsenic concentrations were
measured with a graphite furnace atomic absorption
spectrometer (Analyst 600, Perkin Elmer). The limits of
detection were 0.223 μg/L for lead, 0.087 μg/L for cad-
mium, 0.16 μg/L for manganese, and 1.679 μg/L for
arsenic. The concentrations in all samples were higher
than the limits of detection. The inter-assay coefficients
of variation were 2.2–6.0% for lead, 3.0–11.9% for cad-
mium, 2.2–4.8% for manganese, and 2.5–3.2% for the
urine arsenic assay. Urine creatinine-adjusted arsenic
values were calculated to correct for the effect of differ-
ences in creatinine clearance among the subjects. Blood
mercury concentrations were measured using the gold
amalgam method (DMA-80, Milestone, Sorisole, Italy).
The limit of detection for mercury was 0.05 μg/L, and
the concentrations of all samples were higher than the
limit of detection. The inter-assay coefficient of variation
for the mercury assay was 1.1–4.1%.
Statistical analysis
Differences in blood and urine heavy metal concentra-
tions based on MS status were investigated based on the
health interview and health examination data fromKNHANES 2008. The difference in the prevalence of
MS and high CVD risk was examined by subdividing the
subjects into quartiles based on heavy metal concentra-
tions. Odds ratios (ORs) and 95% confidence intervals
(CIs) for MS were estimated according to the quartile
for each heavy metal concentration. Finally, the correla-
tions between each MS diagnostic component and blood
heavy metal concentrations were evaluated.
PASW (version 18.0) (SPSS, Inc., Chicago, IL, USA)
was used for statistical analyses and data management.
Demographic and biochemical data are presented as
either means ± standard deviations (SD) or proportions,
while heavy metal concentrations are presented as geo-
metric means ± 95% confidence intervals (CI) [16]. An
independent sample t-test and chi-square test were used
to determine statistical significance with respect to MS
status. A linear-by-linear association test was conducted
to verify the significance of the trends for the prevalence
of MS and moderate (5% to < 10%) and high (≥ 10%)
CVD risk subgroups with respect to the quartile for each
heavy metal concentration.
Differences in blood and urine heavy metal concen-
trations based on MS status were determined, and the
influence of other variables was adjusted for by using
analysis of covariance. ORs for the prevalence of MS
were calculated using the lowest quartile subgroup as
the standard, and the effect of confounders was adjusted
for by using logistic regression to investigate the degree
of MS risk based on heavy metal concentration. Linear
trends for ORs were obtained from the significance of
the continuous version of these quartiles entered into
the same model. Multiple linear regression models were
used to clarify the relationships between the diagnostic
components of MS and each heavy metal concentration.
P-values < 0.05 were considered statistically significant.
Ethics statement
Because this study analyzed publicly available data sets,
it exempted from institutional review board approval.
Results
Demographic and clinical characteristics of subjects
according to MS status
A significant difference in demographic and clinical
characteristics was observed among subjects stratified
according to MS status (Additional file 1: Table S1). The
mean age (p < 0.001) and BMI (p < 0.001) of MS subjects
were significantly higher than those of non-MS subjects.
Furthermore, the proportions of males (p < 0.001), current
smokers (p = 0.010), and subjects with low educational
status (p < 0.001) were significantly higher in the group of
MS subjects than the group of non-MS subjects. In
addition to these variables, the proportion of subjects with
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subjects than subjects without MS. Considerable differences
among the subjects were observed for the other biochem-
ical parameters, including total cholesterol (p < 0.001), cre-
atinine (p = 0.008), AST (p < 0.001), ALT (p < 0.001), and
fasting insulin (p < 0.001), which were not included as MS
diagnostic criteria. In contrast, alcohol, location, occupa-
tion, and physical activity, as well as BUN and LDL choles-
terol levels, were not significantly different between MS
and non-MS subjects.
Differences in blood and urine heavy metal
concentrations by MS status
Heavy metal concentrations in subjects were compared
based on MS status. The results of the independent sam-
ple t-test showed that lead, mercury, cadmium, and
creatinine-adjusted urine total arsenic concentrations
were significantly higher in subjects with MS (data not
shown) than in those without MS. However, a significant
difference was found only for the lead concentration
after other clinical and biochemical parameters affecting
MS status were adjusted for in the analysis (p = 0.015,
Table 1). The concentration of mercury tended to be
higher in subjects with MS than those without MS, but
the difference was not significant (p = 0.082).
Prevalence of MS in moderate/high CVD risk subjects
according to lead concentration
The prevalence of MS in subjects according to the log-
transformed lead quartiles increased from 7.7% to 13.7%,
18.5%, and 27.1%, respectively (Figure 1). The proportion
of moderate CVD risk subjects, calculated based on the
Framingham risk score, increased from 2.6% to 7.7%,
10.5%, and 19.1% based on the lead quartiles. High CVD
risk subjects showed increases from 2.3% to 6.6%, 15.3%,
and 30.2% based on lead quartiles (Figure 2). The preva-
lence of MS and the proportion of moderate/high CVD
risk subjects showed trends that were significant accord-
ing to the lead quartile (p < 0.001).Table 1 Blood and urine heavy metal concentrations in
study subjects according to metabolic syndrome (MS)
status adjusted for all other significant variables
MS (−) MS (+) p
n = 1,170 n = 235
Lead (μg/dL) 2.28 (2.23-2.33) 2.45 (2.33-2.58) 0.015
Mercury (μg/dL) 4.62 (4.49-4.76) 4.96 (4.62-5.32) 0.082
Cadmium (μg/L) 0.85 (0.83-0.88) 0.88 (0.82-0.95) 0.401
Manganese (μg/dL) 1.29 (1.27-1.31) 1.33 (1.28-1.38) 0.126
Arsenic (μg/g creatinine) 111.2 (106.9-115.6) 115.5 (105.3-126.6) 0.464
Expressed as geometric mean (95% confidence intervals).
Adjusted for age, sex, smoking, education, total cholesterol, creatinine,
aspartate amino transferase, alanine aminotransferase, and fasting serum
insulin by analysis of covariance.Difference in MS risk based on lead concentration
We next evaluated the ORs and 95% CIs for MS preva-
lence according to the log-transformed lead quartiles
(Table 2). The ORs and 95% CIs for MS of the second,
third, and fourth quartiles compared to the lowest quar-
tile were 1.54 (0.93–2.56), 1.82 (1.10–3.01), and 2.50
(1.50–4.15), respectively, after adjusting for demographic
characteristics, and a significant increase in the trend for
the OR was observed (p < 0.001). After adjusting for bio-
chemical variables, the OR and 95% CI for the highest
quartile was 2.57 (1.46–4.51), which was still significant,
and the trend for the numbers was also significant
(p < 0.001). The ORs for the log-transformed mercury
quartiles increased significantly after adjustment for demo-
graphic variables (p = 0.045, Additional file 1: Table S2).

































p for trend <0.001
p for trend <0.001
Figure 2 Prevalence of moderate (5 to < 10%) and high
( ≥ 10%) 10-year cardiovascular disease risk subjects by log
transformed lead concentration quartile.
Table 2 Adjusted ORs of the study subjects with
metabolic syndrome according to logarithmic
transformed lead quartiles
Model 1* p Model 2** p
OR (95% CI) OR (95% CI)
Quartile 1 Referent - Referent -
Quartile 2 1.54 (0.93-2.56) 0.095 1.56 (0.90-2.71) 0.117
Quartile 3 1.82 (1.10-3.01) 0.020 1.63 (0.94-2.83) 0.081
Quartile 4 2.50 (1.50-4.15) <0.001 2.57 (1.46-4.51) 0.001
p for trend*** 0.001 0.001
OR, odds ratio; CI, confidence interval.
* Model 1 is shown as OR and 95% CI adjusted for age, sex, smoking, and
education.
** Model 2 is shown as OR and 95% CI further adjusted for total cholesterol,
creatinine, aspartate amino transferase, alanine aminotransferase, and fasting
serum insulin.
*** Linear trend obtained from the significance of the continuous version of
these quartiles entered into the same model.
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Additional file 1: Table S2), and no remarkable findings
were observed for the other heavy metals.Correlation between the diagnostic components of MS
and lead concentration
We evaluated if there was a correlation between the
diagnostic components of MS and blood lead concentra-
tion (Table 3). In multivariate regression analysis, which
included demographic variables, triglyceride level was
significantly associated with blood lead level (p = 0.007).
Additionally, serum triglyceride level remained signifi-
cantly associated with blood lead in the multivariate
regression analysis, which included demographic and
biochemical confounders (p = 0.006). No other remark-
able findings were observed for the other heavy metals
(data not shown).Table 3 Adjusted regression coefficients of diagnostic
components for metabolic syndrome with log-
transformed lead in the study subjects
Model 1* Model 2**
Standardized β p Standardized β p
Abdominal
circumference
0.035 0.181 0.051 0.073
Triglyceride 0.068 0.007 0.080 0.006
HDL
cholesterol
0.022 0.389 0.033 0.225
Systolic BP 0.016 0.543 0.020 0.457
Fasting
glucose
0.014 0.567 0.019 0.437
* Model 1, adjusted for age, sex, smoking, and education.
** Model 2, further adjusted for total cholesterol, creatinine, aspartate amino
transferase, alanine aminotransferase, and fasting serum insulin.Discussion
We investigated the association between MS and envi-
ronmental exposure to heavy metals based on the 2008
KNHANES data, which were obtained from a representa-
tive sample of the noninstitutionalized civilian population
of Korea. We found that environmental factors, particu-
larly blood lead level, as well as recognized conventional
risk factors for MS significantly affected MS and its rele-
vant pathophysiology.
Blood lead was the only heavy metal that showed a
significant association with MS after adjustment for
demographic and biochemical parameters. The preva-
lence of MS in the study subjects increased significantly
according to log-transformed lead quartiles. The preva-
lence of moderate to high CVD risk subjects, as esti-
mated by the Framingham risk score, also showed a
significant increasing trend according to lead quartile.
Moreover, the ORs of MS by lead quartile were signifi-
cantly high, with trends that increased progressively
according to lead quartile. Mercury, cadmium, arsenic,
and other heavy metals also increased significantly in
subjects with MS when the effects of confounders were
not adjusted for. However, no significant differences
were observed after adjustment. The other heavy metals
did not demonstrate any meaningful trends in the ORs
for MS when compared by quartiles. These results sug-
gest that environmental lead exposure is closely asso-
ciated with the prevalence of MS and a high CVD risk.
People can be exposed to lead through contaminated
air, water, soil, food, and consumer products, and they
can inhale and ingest lead [17]. After inhalation or inges-
tion, lead is absorbed into the body through the mucous
membranes. Environmental lead is ubiquitous, which
means that most people in the world probably have trace
blood lead levels [18]. Lead exposure has decreased dras-
tically since leaded gasoline was banned internationally
and since the use of lead compounds began to decline in
the 1970s. However, substantial amounts of lead are still
utilized in industrial products [19]. About 15% of the
lead to which a person is exposed is absorbed into the
body; however, children, pregnant women, and patients
with calcium, zinc, or iron deficiencies are likely to ab-
sorb much more [20,21]. Lead accumulates in the blood,
soft tissues, and bone. Small amounts of lead are stored
in the brain, spleen, kidneys, liver, and lungs [17,22].
Lead that has accumulated in the body is eliminated very
slowly through the urine and is also excreted through
the stool, nails, and sweat [17]. The estimated half-life of
lead in bones is 20–30 years, and these organs could be
a source of lead continuously released into the blood-
stream [17]. The half-life of lead in the blood of adults is
about 40 days. However, blood lead has a longer half-life
in children and pregnant women, as their bones are
rapidly remodeled, which translates into increased blood
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sured to evaluate lead exposure, but the total amount of
accumulated lead in the body is not accurately reflected by
this measurement [23]. The World Health Organization
and the U.S. Centers for Disease Control and Prevention
announced that blood lead levels > 10 μg/dL may affect
health [20,24]. However, the definitive level for safe expo-
sure to lead has not yet been identified, because blood lead
levels < 10 μg/dL can also cause health problems [20,24].
Chronic lead exposure is detrimental to health. Chronic
exposure to low-level lead can cause depletion of gluta-
thione and protein-bound sulfhydryl groups, resulting in
an increase in reactive oxygen species and damage to cell
structures, including DNA and cell membranes [25].
Chronic lead exposure inhibits DNA transcription, vitamin
D synthesis, and the function of enzymes that maintain cell
membrane integrity. Lead also alters the permeability of
blood vessels and the synthesis of collagen [26]. Addition-
ally, lead can have harmful effects on immune system de-
velopment and cause production of excessive inflammatory
proteins [27]. As a result, lead may cause an increase in
levels of proinflammatory mediators and lipid peroxidation,
suppress nitric oxide levels, change calcium homeostasis, as
well as alter autonomic function and heart rate variability,
which, in turn, could increase the likelihood of hyperten-
sion and CVD [25,28].
Another remarkable finding of this study was that
serum triglyceride level was the only diagnostic compo-
nent of MS significantly associated with blood lead level
in multiple linear regression analysis. Some researchers
have found that acute or chronic lead exposure does not
greatly change triglyceride levels, or may even reduce
levels [29,30]. However, direct comparison of our results
with investigations that focused on subjects living in
areas with high endemic lead concentrations is not
appropriate. A previous experimental study also reported
that lead exposure causes hypertriglyceridemia, and the
VA Normative Aging Study, a population-based study
performed to investigate the effects of low-level lead
exposure, reported similar results to our study [25,31].
Our study has some limitations. First, as KNHANES
2008 was a cross-sectional study, a causal relationship
between heavy metals and MS cannot be determined.
Second, the heavy metal exposure status was evaluated
only by blood samples, not by bone or soft tissue samples.
As a result, the measurements may not accurately reflect
chronic exposure status. Third, MS is defined as a cluster
of insulin resistance-associated components, such as ab-
dominal obesity, dyslipidemia, hypertension, and hypergly-
cemia, and it is not clear whether MS should be regarded
as a single disease entity [32]. Despite these limitations,
our study results are meaningful, because they revealed a
significant association between blood lead concentration
and MS in a large number of subjects representative ofthe entire Korean population. All study subjects under-
went accurate heavy metal analyses with strict quality
controls, and a significant association between blood lead
level and MS was identified after adjusting for demo-
graphic and social characteristics. Furthermore, because
previous studies have already revealed that MS is closely
related to high CVD risk, MS should be a useful clinical
target for treatment, regardless of debate regarding its def-
inition [33-35]. In fact, many clinical practice guidelines
recommend MS management, and some communities
and countries have been actively conducting intervention
campaigns to prevent and manage MS [10,36]. Thus, our
finding that low-level lead exposure is a risk factor for
CVD is meaningful.
Conclusions
We found that blood lead concentration was significantly
associated with the risk for MS and CVD, and that blood
lead concentration had a close relationship with the serum
triglyceride level, which is one of the diagnostic compo-
nents of MS. Future large-scale longitudinal studies that
overcome the limitations of the current study will provide
a more detailed view of the pathophysiological role of en-
vironmental exposure to lead in patients with MS.Additional file
Additional file 1: Table S1. Demographic and clinical characteristics of
the study subjects by metabolic syndrome. Table S2. Adjusted odds
ratios of the study subjects with metabolic syndrome by logarithmic
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